Tissue decellularization produces a three-dimensional scaffold that can be used to fabricate functional liver grafts following recellularization. Inappropriate cell distribution and clotting during blood perfusion hinder the practical use of recellularized livers.
Here we aimed to establish a seeding method for the optimal distribution of parenchymal and endothelial cells, and to evaluate the effect of liver sinusoidal endothelial cells (LSECs) in the decellularized liver. Primary rat hepatocytes and LSECs were seeded into decellularized whole-liver scaffolds via the biliary duct and portal vein, respectively. Biliary duct seeding provided appropriate hepatocyte distribution into the parenchymal space, and portal vein-seeded LSECs simultaneously lined the portal lumen, thereby maintaining function and morphology. Hepatocytes co-seeded with LSECs retained their function compared with those seeded alone. Platelet deposition was significantly decreased and hepatocyte viability was maintained in the co-seeded group after extracorporeal blood perfusion. In conclusion, our seeding method provided optimal cell distribution into the parenchyma and vasculature according to the three-dimensional structure of the decellularized liver. LSECs maintained hepatic function, and supported hepatocyte viability under blood perfusion in the engineered liver graft owing to their antithrombogenicity. This recellularization procedure could help produce practical liver grafts with blood perfusion.
K E Y W O R D S
animal models: murine, artificial organs/support devices, basic (laboratory) research/science, cellular biology, liver transplantation/hepatology, tissue/organ engineering substituted liver transplantation due to their limited efficacy. 1, 2 Thus engineering a transplantable and functional liver represents an attractive strategy to resolve these problems.
Decellularized liver scaffolds have recently been reported for application in whole-liver engineering. [3] [4] [5] The decellularized threedimensional (3D) liver scaffold consists of an extracellular matrix (ECM) forming a microvasculature for nutrient and gas transport, and molecules that may promote cell attachment and tissue generation. 6, 7 A decellularized liver scaffold is a promising material for tissue engineering; however, no clinically relevant recellularized liver graft has yet been achieved. In addition to the lack of abundant cell sources to ensure sufficient and effective recellularization, the main challenges include an inappropriate cell distribution in the complex 3D liver scaffold and clotting during blood perfusion, which lead to insufficient liver function in vivo. Therefore, efficient reestablishment of the parenchyma and vasculature needs to be achieved to produce a functional and transplantable recellularized liver.
In previous studies, the portal vein (PV) was used primarily as a seeding route for parenchymal cells. [3] [4] [5] 8 However, mechanical stress caused by the perfusate is inevitable, lasting several days during the migration process of recellularized cells into the parenchymal space.
3
In addition, parenchymal cells seeded via the PV disturb portal blood flow into the portal lumen, and prevent the engraftment of endothelial cells along the vasculature. We have previously reported the efficient repopulation of parenchymal cells through the biliary duct (BD).
9
Because of direct contact between the parenchymal space and the biliary tree, BD seeding of parenchymal cells represents an appealing method not only to avoid injury caused by the pressure of the perfusate on the PV, but also to maintain the portal lumen, which can then be used as a seeding route for endothelial cells to prevent clotting during blood circulation.
Several studies attempting the transplantation of a recellularized liver in vivo have demonstrated blood clotting in the scaffold. To produce functional liver grafts for blood perfusion, we devel- 
| MATERIALS AND METHODS

| Animals
Male Lewis rats or transgenic rats carrying the green fluorescent protein (GFP) gene (SLC, Hamamatsu, Japan) weighing 250-300 g were used for preparing the 3D liver scaffold and primary cell isolation. Male Lewis rats (SLC) weighing approximately 400 g were used for extracorporeal perfusion. The rats were maintained on a standard laboratory diet and water ad libitum, and were housed in a temperature-and humidity-controlled environment under a constant 12-hour light/dark cycle in the animal facility at Kyoto
University. All animal experiments were approved by the Kyoto University Animal Experimentation Committee and were performed in accordance with Kyoto University Animal Protection Guidelines.
| Liver harvest and decellularization
Liver harvesting and preparation of the 3D liver scaffold were performed according to our previous report. 9 In brief, the harvested liver previously cannulated with a 24-gauge cannula in the BD and 
| Isolation of primary hepatocytes and LSECs
Hepatocytes were obtained using a 2-step collagenase perfusion technique as described previously, 19 and LSECs were isolated by Percoll centrifugation with minor modifications. 18, 20 Details of the cell isolation procedure are provided in Supporting Information and Figure S1 .
| Recellularization and re-endothelialization of liver scaffolds
A decellularized liver scaffold was placed in a 100-mm culture dish and then perfused with 20 mL of co-culture medium for hepatocytes and LSECs through the PV prior to recellularization. The co-culture medium consisted of RPMI 1640 medium (Sigma-Aldrich, St. Louis, MO) with 10% fetal calf serum (ICN, Aurora, OH), 0.6 μg/mL insulin (MP Biomedicals, Santa Ana, CA), 10 ng/mL VEGF (R&D, Minneapolis, MN, USA), 10 ng/mL epidermal growth factor (PeproTech, London, UK), 100 U/mL penicillin G and 100 μg/mL streptomycin (Meiji Seika, Tokyo, Japan), 20 μg/mL gentamycin (Sigma-Aldrich), and 50 ng/mL amphotericin B (Wako, Osaka, Japan). For recellularization into the parenchymal space, we introduced a total of 3 × 10 7 hepatocytes suspended in 30 mL of the culture medium into the scaffold through the BD. For re-endothelialization into the vasculature, a total of 1.5 × 10 7 LSECs or HUVECs suspended in 3 mL of the culture medium was injected into the scaffold through the PV. We seeded rat hepatocytes at a dose sufficient to be distributed in each lobe of the whole-liver scaffold, and LSECs at a quantity sufficient to cover the portal lumen including microvasculature. At each step, we injected the cell suspension into the scaffold at a flow rate of 1 mL/min.
| Perfusion culture of the recellularized liver graft
After 3 hours of static culture for cell attachment, we transferred the recellularized liver graft into a customized chamber for in vitro perfusion culture. The cannula inserted into the PV of the recellularized liver graft was connected to a recirculation circuit and continuously perfused with the co-culture medium for 1 week using a peristaltic pump at a sub-physiological flow rate of 0.5 mL/min, to attenuate shear stress to seeded hepatocytes, as described previously. 9 The medium was changed every 48 hours, and samples were obtained to analyze protein secretion levels. Histological analysis of the cultured recellularized livers was performed on day 2 and day 6 of perfusion culture.
| Extracorporeal blood perfusion of the recellularized liver graft
We placed the recellularized liver graft in the extracorporeal blood perfusion system using a live rat to evaluate the antithrombotic ability of endothelial cells and the feasibility of our recellularized liver for blood perfusion. The extracorporeal perfusion system incorporated with our fabricated liver graft ( Figure S2 ) was established based on the circuit of an extracorporeal bioartificial liver. 21 Under general anesthesia with isoflurane (Wako), cannulation of the left carotid artery and the right jugular vein was performed using a PE 50 polyethylene tube (Becton Dickinson and Co., Sparks, MD) and a 0.5 × 1 mm silicone tube (As One, Osaka, Japan), respectively. The circuit was primed with heparinized (10 units/mL) saline solution, and then after 2 days of perfusion culture, our fabricated liver graft was put in the extracorporeal perfusion system. The rats were administered 100 units heparin intravenously 5 minutes before the start of extracorporeal perfusion. To compensate for the dead volume of the circuit, 5 mL of fresh rat blood was transfused immediately before perfusion.
Subsequently, the arterial and venous lines were connected to the extracorporeal circuit. Arterial blood was pumped into the PV cannula inserted in the recellularized liver graft at a flow rate of 1.0 mL/ min, which is slower than the physiological flow to minimize the shear stress to the engrafted cells. The blood through the liver graft was drained from the inferior vena cava (IVC) and returned to the jugular vein at the same flow rate by digital variable-speed infusion pumps (Top, Tokyo, Japan). During the perfusion, heparinized saline solution (40 units/mL) was continuously administered just before the recellularized liver graft at a flow rate of 0.3 mL/h to prevent coagulation in the graft and circuit due to blood perfusion. Histological analysis of liver grafts was performed after 3 hours of extracorporeal blood per- 
| Scanning electron microscopy examination
Re-endothelialized liver grafts with LSECs after 2 days of perfusion culture were perfused with 2% glutaraldehyde and 4% paraformaldehyde (PFA) in PBS, and cut into 5-mm 3 pieces. The samples were fixed in 2% glutaraldehyde and 4% PFA in PBS at 4°C overnight, and then ion-sputter-coated. Samples were observed with a Hitachi S-4700 scanning electron microscope (Hitachi, Tokyo, Japan).
| Liver function analysis
Albumin content in the medium was measured using a rat albumin enzyme-linked immunosorbent assay (ELISA) quantification kit (Bethyl Laboratories, Montgomery, TX). Urea content in the medium was analyzed using the QuantiChrom Urea Assay Kit (BioAssay Systems, Hayward, CA), according to the manufacturer's protocol.
Total bile acids were measured by a standard spectrophotometric method with an automated analyzer (JEOL Ltd., Tokyo, Japan).
| Statistical analysis
Data are expressed as the mean ± standard error of the mean (SEM).
We performed statistical analyses using GraphPad Prism, version 6.0 (GraphPad Software, La Jolla, CA). Statistical significance was defined as P < .05. Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL)-positive cells and deposition of platelets were compared using Student's t-test. The metabolic activity of recellularized liver grafts was compared using repeated-measures analysis of variance (ANOVA), followed by Bonferroni post hoc tests (additional information about the materials and methods is provided in Supporting Information).
| RESULTS
| Decellularization of the whole liver
An acellular whole-liver scaffold was obtained by portal perfusion after 24 hours of the decellularization procedure ( Figure 1A ). Histological analysis confirmed the lack of nuclei or cytoplasmic components in the decellularized liver scaffold ( Figure 1B) . Crystal violet staining confirmed that the PV and BD, serving as routes for recellularization, were retained and patent to the peripheral capillaries after decellularization ( Figure 1C-F) . The infused dye flowed out from the vasculature and distributed into the parenchymal space without leakage from the surface of the liver in the late phase of both PV ( Figure 1D ) and BD ( Figure 1F ) staining, and finally drained to the IVC.
| Recellularization of hepatocytes into the parenchymal space with BD seeding
Macroscopic observation of the liver recellularized with primary rat hepatocytes by BD seeding demonstrated that hepatocytes were distributed in each lobe of the whole-liver scaffold and spread outside of the biliary tree ( Figure 2A ). Hematoxylin and eosin (H&E) staining of the recellularized liver graft on day 2 of perfusion culture revealed an appropriate cell distribution of the hepatocytes into the parenchymal space without intravascular embolus ( Figure 2B ).
Immunohistochemical staining after 2 days of perfusion culture
showed that albumin and UDP glucuronosyltransferase 1 family, polypeptide A1 (UGT1A1) expression in the recellularized liver was similar to that in the normal liver ( Figure 2C ). Furthermore, dipeptidyl peptidase-4 (DPPIV) or CD26, a known marker of bile canaliculi, was detected in sections of the recellularized liver graft ( Figure 2C ). This result provides evidence that cell polarity of hepatocytes was organized in the engineered liver graft, possibly reproducing the channels through which bile acids were secreted. 
| Co-seeding of hepatocytes and LSECs: optimal cell distribution and maintenance of hepatic function
After recellularization of hepatocytes into the parenchymal space with BD seeding, we performed re-endothelialization of LSECs into the vasculature with PV seeding, and proceeded with perfusion culture for 1 week ( Figure 4A,B) . H&E staining on day 2 of perfusion culture
showed an appropriate cell distribution of hepatocytes into the parenchymal space and of LSECs into the portal vasculature ( Figure 4C ).
Thus the hepatocytes recellularized via BD seeding did not obstruct the portal lumen, allowing for proper attachment of LSECs.
To assess the interaction between LSECs and hepatocytes, we compared metabolic activity between the Hep + LSEC and Hep groups during perfusion culture. Cumulative albumin secretion and urea synthesis levels were significantly higher in the Hep + LSEC group than in the Hep group (P = .006 and .003, respectively; Figure 5A ,B). These results suggest that LSECs maintained hepatocyte function during the perfusion culture. Although total bile acids secretion levels were higher in the Hep + LSEC group than in the Hep group, the difference was not statistically significant (P = .313; Figure 5C ). We further compared the metabolic activity between the Hep + HUVEC and Hep groups during the perfusion culture. Cumulative albumin secretion and urea synthesis levels were higher in the Hep + HUVEC group than in the Hep group; however, differences between groups were not statistically significant (P = .068 and .516, respectively; Figure 5A ,B).
Similarly, there was no statistically significant difference in total bile acid secretion levels ( Figure 5C ).
The numbers of TUNEL-positive cells among hepatocytes were higher in the Hep group than in the Hep + LSEC group on day 2 of perfusion culture, with a large disparity observed by day 6; however, differences between the groups were not statistically significant (P = .408 and .100, respectively; Figure 5D ).
| Evaluation of the engineered liver graft after extracorporeal blood perfusion
Following 2 days of perfusion culture, we placed the engineered liver grafts in an extracorporeal perfusion system ( Figure 6A ) and performed blood circulation into the liver graft for 3 hours. All of the rats tolerated the extracorporeal perfusion and no death was observed.
The blood filled into the scaffold in about 10 minutes via the PV and finally drained to the IVC ( Figure S2 ). Although some clots were ob- Figure 6F ). Furthermore, the Hep + HUVEC group exhibited significantly lower platelet deposition than the Hep + LSEC group (P < .001; Figure 6F ). At the same time, no significant difference between the 3 groups was observed in terms of platelet deposition in the central vein system, which was not re-endothelialized ( Figure S5 ).
The number of TUNEL-positive hepatocytes increased after ex- 
| DISCUSSION
Organ decellularization is a recently well-established and reproducible technique, [3] [4] [5] 8, 11 allowing for a whole-liver decellularized scaffold to be obtained from rodent, porcine, or even human livers. 8, 11, [23] [24] [25] Although engineered livers derived by decellularization were expected to regenerate transplantable liver grafts, no study has yet In conclusion, our proposed seeding method provided optimal cell distribution into the parenchyma as well as the vasculature following the 3D structure of the decellularized liver. LSECs supported hepatocyte viability under blood perfusion, maintaining hepatocyte function and suppressing thrombus formation in the engineered liver graft. The recellularization procedure described in this study is expected to help produce functional liver grafts under blood perfusion.
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